TrialNCT05733780Phase 2Unknown
To Evaluate the Safety, Efficacy,and Pharmacokinetics of Orally Administered Prolectin-M
Study sponsor: Bioxytran Inc.
Compare the available registry edits below. Primary completion is the date data collection ends for the main study measures; it does not tell you when results will be published.
Primary completion2023-12Estimated
Enrollment · participants40Estimated
Source updated2023-09-28Last update listed in the registry record
Version history
Changes to this trial
Pro unlocks the full available history and CSV export. View Pro features
No recorded changes are available for this view and time period. Our history may be incomplete; this does not establish that the trial stayed unchanged.